Header Logo

Connection

AHSAN RIZVI to Lactams, Macrocyclic

Back to Details
This is a "connection" page, showing publications AHSAN RIZVI has written about Lactams, Macrocyclic.
AHSAN RIZVI
Connection Strength
0.160
Lactams, Macrocyclic
  1. Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer. Clin Cancer Res. 2020 01 01; 26(1):242-255.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.